KRAS and cancer: For example, the occurrence of KRAS alterations in the current study (49.5%) was higher than that reported at cBioPortal, a resource hosting genomic data from large cancer sequencing consortiums and individual studies (44.7%) (Supplementary Table S5) [19,20].